Abstract
We describe a patient with AML with a monocytic component who developed a T-lymphoblastic lymphoma. Lymphoma was diagnosed 9 months following AML diagnosis. To our knowledge, this is the first report of phenotypically documented T-cell lymphoma following AML. The questions relating to the pathogenesis of the two malignancies are discussed.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Blast Crisis
-
Bone Marrow / pathology
-
Fatal Outcome
-
Female
-
Humans
-
Immunophenotyping
-
Karyotyping
-
Leukemia, Myeloid, Acute / diagnosis*
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / immunology
-
Leukemia, Myeloid, Acute / pathology
-
Lymphoma, T-Cell / diagnosis*
-
Lymphoma, T-Cell / drug therapy
-
Lymphoma, T-Cell / immunology
-
Lymphoma, T-Cell / pathology
-
Neoplasms, Second Primary / diagnosis*
-
Neoplasms, Second Primary / drug therapy
-
Neoplasms, Second Primary / immunology
-
Neoplasms, Second Primary / pathology
-
Pleural Effusion
-
T-Lymphocytes / immunology
-
T-Lymphocytes / pathology